Allied Market Research

Erectile Dysfunction Drugs Market: Competitive Developments, Leading Players and Their Core Competencies

Erectile dysfunction is also termed as impotence and it is characterized by incapability to build up or sustain a penile erection during sexual intercourse.


Portland, OR -- (SBWIRE) -- 12/28/2017 -- An Erection of penis involves hydraulic effect resulting from entry and retention of blood into spongy bodies within penis. Sexual arousal is responsible for initiation of this process which is signalized by impulse mechanism from brain to penile nerves. The causes of erectile dysfunction involve side effects of drugs, Cavernosal disorders, Neurogenic disorders, Aging, Psychological causes, Multiple sclerosis and Diabetes, and Lifestyle modifications. Pin-point analysis of global erectile dysfunction drugs market focuses on various aspects of market such as, market trends, market drivers, restrains and opportunities. Competitive landscape section focuses on key leaders within global erectile dysfunction drugs market and their major growth strategies. Deep-dive assessment of segments identifies the potential segment which would act as guide to strategist.

Get the PDF of Erectile Dysfunction industry insights @

The demand for erectile dysfunction therapeutics is highly increasing due to high incidence of chronic diseases including neurogenic disorders, hypertension, diabetes and psychological disorders. Additionally, increasing aged population, patient education and awareness are some of the factors which also fuel the growth of this market. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On contrary, it will provide the key opportunity for generic manufacturers to enter the market. Amongst erectile dysfunction drug users, there is high prevalence of sexually transmitted diseases (STDs) and it could restrain the growth of this market. Generic drugs are the promising opportunity for this market. Moreover, novel drug delivery techniques can also potentiate the market growth.

Do purchase inquiry @

Global Erectile Dysfunction Drugs Market by Therapeutics

The global erectile dysfunction drugs market by therapeutics is segmented into two categories such as, existing drugs and pipeline drugs. Existing drugs includes the major drug brands namely, Viagra, Levitra/Staxyn, Cialis, Zydena, Helleva, Stendra/Spedra Avanafil and Mvix. Viagra was the blockbuster drug by Pfizer which has generated large revenue for the company. Levitra and Cialis are the major competitor for Viagra and these two brands has also captured a potential market share. Owing to the patent expiration of these major brands during forecast period, market is going to experience a decline in total revenue for erectile dysfunction drugs.


This report offers the following benefits in particular:
- In-depth coverage of global erectile dysfunction drugs market including drivers, restrains and opportunities would assist professionals to understand the market behavior
- Pin-point analysis of geographic segments helps to recognize and exploit future opportunities within global erectile dysfunction drugs market
- Comprehensive focus on key patentable brands an its market share along with patent expiration study would be fruitful for generic manufacturers
- Porter's five forces analysis examines competitive structure of global erectile dysfunction drugs market and would assist strategist in decision making